Michael Straughen, Director at CORE LABORATORIES N V (CLB), bought 106 shares at $118.65 ($13K) on 2017-02-01, disclosed to the SEC on 2017-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.